... less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who ... online June 10 in the Journal of the National Cancer Institute. The drug did not reduce the risk ...
... linked to a small reduction in estrogen receptor-positive breast cancers. However, unlike in some previous ... aged 51–72 with no history of cancer.
Unlike other NSAIDs, aspirin has irreversible effects ...
... tumors, tamoxifen begins to act like estrogen and can actually stimulate tumor growth, he ... then tested various agents in estrogen receptor-positive breast cancer cells in the laboratory. The team ...
... to lymph-node negative, estrogen-receptor positive breast cancer, this new genomic test is ... analyzed the gene activity of more than 1,000 breast tumors to identify and validate the genetic signature of ...
... they don't respond well to anti-estrogen therapy. Until now, doctors had no way ... As soon as patients are diagnosed with estrogen-receptor-positive breast cancer, they would be placed on an anti-estrogen ...
... presented at the CTRC-AACR San Antonio Breast Cancer Symposium. Zoledronic Acid May Have Anti- ... inhibitors (AIs) for postmenopausal estrogen-receptor-positive breast cancer given either as initial ...
... Ras since nearly a third of all human cancers involve a mutation in the Ras gene that causes ... premenopausal women with estrogen-receptor-positive breast cancer. Similar results were reported previously ...
... , ovarian, renal cell, and estrogen-receptor positive breast cancers.
To investigate whether dietary acrylamide intake is associated with lung cancer risk, Janneke G. F. Hogervorst, M.Sc., ...
... entirely unexpected way. Their study, being presented at the Cancer Therapy & Research Center-American Association ... Tamoxifen is designed to treat estrogen-receptor positive breast cancer (70-80 percent ...
... GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published ... Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen ...
... factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of ...
